| Price | $4.57 |
| Year Range | $4.52 – $9.56 |
| Market Cap | $274M |
| Industry | Biotechnology |
What Is Vanda Pharmaceuticals’s AI Stock Analysis?
Vanda Pharmaceuticals’s AI stock analysis on AltIndex combines the company’s fundamentals, price technicals and 25+ alternative data signals — like hiring, web traffic, app downloads and online sentiment — into a single AI Score from 0 to 100 and a plain-English Buy, Hold or Sell read. Unlike a traditional analyst rating that updates a few times a year, the AI Score refreshes as new data arrives, so it tracks Vanda Pharmaceuticals’s momentum in near-real time.
Vanda Pharmaceuticals (VNDA) has an AltIndex AI Score of 47/100, currently a Hold signal. The AI Score distills Vanda Pharmaceuticals's fundamentals, price technicals and 25+ alternative data signals into a single 0–100 rating, so a rising score reflects strengthening data across the board and a falling score the opposite.
Vanda Pharmaceuticals’s Full AI Analysis
Keep reading AltIndex’s full AI analysis of Vanda Pharmaceuticals — the fundamental, technical and alternative-data breakdown and the recommendation.
Sign up to read the full analysisWhat’s Driving VNDA’s AI Score?
Fundamentals
Revenue for the last quarter was $51M. This represents a decrease of 2.30% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 3.92%, which may be a cause for concern. Net income for the last quarter was $-63M. This represents a decrease of 28.71% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 129.77%, which may be a cause for concern. Ebitda for the last quarter was $-63M. This represents a decrease of 40.87% compared to the quarter before it, indicating a need for concern. However, compared to the same quarter last year, there is a decrease of 92.42%, which may be a cause for concern.
See Vanda Pharmaceuticals’s earnings and insider transactions.
Technicals
Today's stock price is $4.57. This represents a decrease of 9.33% compared to a month ago, which may be concerning in the short-term. However, compared to a year ago, there is a decrease of 13.94%, which could be a cause for long-term concern. The trend is bearish. The current SMA10 is $4.64, which is lower than the previous SMA10 of $4.68. This suggests a potential downward trend in price movement. The RSI is 64.6, indicating a neutral condition.
See the full technical analysis and price prediction.
Alternative data
Vanda Pharmaceuticals has an estimated 99 open positions. This number is up by 22% in the last couple of months, indicating a company that looking to grow and expand. Potentially a healthy sign. The business outlook among employees at Vanda Pharmaceuticals is neutral. Vanda Pharmaceuticals has an estimate of 14,000 visitors to their webpage. The number of visitors is down by -26% in the last couple of months, a worrisome trend as this can indicate a loss in customers.
Explore Vanda Pharmaceuticals’s job postings, web traffic and app downloads.
Sentiment & social
Vanda Pharmaceuticals has 1,800 followers on their Twitter page. The number of followers is down by -2% in the last couple of months, indicating a loss in interest in the company.
Track Vanda Pharmaceuticals’s market sentiment.
Frequently Asked Questions: Vanda Pharmaceuticals AI Stock Analysis
Vanda Pharmaceuticals's AltIndex AI Score is 47/100, currently a Hold signal. The AI Score blends fundamentals, technicals and 25+ alternative data signals into a single rating from 0 to 100.
AltIndex's AI Score model rates Vanda Pharmaceuticals a Hold (47/100). This is a data-driven signal, not investment advice — review the breakdown above and combine it with your own research.
The AI Score is generated from fundamental data (earnings, valuation), technical indicators (price trend and momentum), and alternative data signals such as hiring, web traffic, app downloads and sentiment. AltIndex weighs these into a single 0-100 score; the exact weighting is proprietary.
AltIndex generates a complete written AI analysis of Vanda Pharmaceuticals — company overview, fundamentals, technicals and alternative data, with a recommendation. See the VNDA AI Score or sign up to read the full thesis.
